Ambee Pharmaceuticals PLC (DSE:AMBEEPHA)

Ambee Pharmaceuticals Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 12, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	1,927	1,960	1,829	1,318	1,260	985
Market Cap Growth	-3.35%	7.12%	38.81%	4.57%	27.92%	-14.60%
Enterprise Value	2,489	2,445	2,240	1,629	1,521	1,202
Last Close Price	802.80	815.42	760.13	546.57	521.71	407.85

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 12, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
PE Ratio	348.58	369.08	188.91	144.98	156.37	-
PS Ratio	12.22	8.50	8.34	6.65	6.96	9.95
PB Ratio	54.49	60.61	62.17	56.46	23.92	21.97
P/TBV Ratio	54.49	60.61	62.17	56.46	23.92	21.97
P/OCF Ratio	-	90.16	-	-	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 12, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
EV/Sales Ratio	15.79	10.61	10.22	8.22	8.40	12.14
EV/EBITDA Ratio	281.11	196.29	122.73	80.79	77.41	-
EV/EBIT Ratio	-	330.94	180.50	123.64	102.35	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 12, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Debt / Equity Ratio	18.68	19.76	0.03	16.82	6.55	5.35
Debt / EBITDA Ratio	74.58	49.53	0.05	18.95	16.49	-
Net Debt / Equity Ratio	15.91	15.66	-1.08	15.59	6.22	5.01
Net Debt / EBITDA Ratio	66.20	40.65	-1.75	18.05	16.70	-134.45
Net Debt / FCF Ratio	-30.56	-245.76	0.47	-10.30	-4.39	-41.23
Asset Turnover	0.21	0.35	0.40	0.39	0.39	0.23
Inventory Turnover	0.36	0.55	0.49	0.49	0.54	0.40
Quick Ratio	0.44	0.47	0.38	0.34	0.29	0.29
Current Ratio	0.85	0.83	0.91	0.88	0.92	0.87
Return on Equity (ROE)	16.36%	17.19%	36.70%	23.91%	16.53%	-25.34%
Return on Assets (ROA)	0.34%	0.70%	1.41%	1.62%	2.01%	-1.07%
Return on Invested Capital (ROIC)	0.50%	2.00%	5.28%	2.92%	3.60%	-2.68%
Return on Capital Employed (ROCE)	10.40%	20.30%	36.30%	44.70%	24.80%	-13.70%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 12, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Earnings Yield	0.29%	0.27%	0.53%	0.69%	0.64%	-1.32%
FCF Yield	-0.96%	-0.10%	-3.72%	-2.68%	-5.93%	-0.55%
Dividend Yield	0.12%	0.12%	0.13%	0.27%	0.19%	-
Payout Ratio	39.37%	44.23%	34.91%	11.00%	18.61%	-
Total Shareholder Return	0.12%	0.12%	0.13%	0.27%	0.19%	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 11, 2026

Data Sources Report a data error